Dapsone as first line therapy for bullous pemphigoid.

In an open study, a total of 18 patients with proven bullous pemphigoid (16 new patients and two in relapse) were treated with a trial of dapsone (17 patients) or sulphonimide (one patient). Overall, eight patients were controlled on one of these agents as the sole treatment (44%). Six patients had...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Venning, V, Millard, P, Wojnarowska, F
Formatua: Journal article
Hizkuntza:English
Argitaratua: 1989

Antzeko izenburuak